These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1394156)

  • 1. Immunosuppressive therapy and acquired immunological disorders.
    Kinlen L
    Cancer Res; 1992 Oct; 52(19 Suppl):5474s-5476s. PubMed ID: 1394156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for non-Hodgkin's lymphomas].
    Ferrís Tortajada J; García Castell J; Berbel Tornero O; Clar Gimeno S
    An Esp Pediatr; 2001 Sep; 55(3):230-8. PubMed ID: 11676898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM
    Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors.
    Pearce N; Bethwaite P
    Cancer Res; 1992 Oct; 52(19 Suppl):5496s-5500s. PubMed ID: 1394162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of non-Hodgkin's lymphoma.
    Fisher SG; Fisher RI
    Oncogene; 2004 Aug; 23(38):6524-34. PubMed ID: 15322522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology.
    Müller AM; Ihorst G; Mertelsmann R; Engelhardt M
    Ann Hematol; 2005 Jan; 84(1):1-12. PubMed ID: 15480663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental and occupational aspects on the etiology of non-Hodgkin's lymphoma.
    Hardell L; Axelson O
    Oncol Res; 1998; 10(1):1-5. PubMed ID: 9613451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of non-Hodgkin's lymphoma: recent data].
    Chassagne-Clément C; Blay JY; Treilleux I; Sebban C; Bergeron C; Biron P; Philip T
    Bull Cancer; 1999 Jun; 86(6):529-36. PubMed ID: 10417426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative diseases in disorders of the immune system.
    Penn I
    Cancer Detect Prev; 1990; 14(4):415-22. PubMed ID: 2224906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pesticides and non-Hodgkin's lymphoma.
    Zahm SH; Blair A
    Cancer Res; 1992 Oct; 52(19 Suppl):5485s-5488s. PubMed ID: 1394159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered immunity as a risk factor for non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM; Cozen W
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):405-8. PubMed ID: 17337643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
    Broccia G; Cocco P; Casula P;
    Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood social environment and risk of non-Hodgkin lymphoma in adults.
    Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami HO; Melbye M
    Cancer Res; 2007 Nov; 67(22):11074-82. PubMed ID: 18006854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
    Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
    Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of non-Hodgkin's lymphoma: why the increased incidence?
    Palackdharry CS
    Oncology (Williston Park); 1994 Aug; 8(8):67-73; discussion 73-8. PubMed ID: 7947004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological deficiency syndromes, immunosuppression by drugs and occurrence of neoplasms: a casual association?].
    Dammacco F; Iodice G; Romagno D; Campobasso N
    Ric Clin Lab; 1985; 15 Suppl 2():11-23. PubMed ID: 4095454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence.
    Hartge P; Devesa SS
    Cancer Res; 1992 Oct; 52(19 Suppl):5566s-5569s. PubMed ID: 1394175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.